MAPT and Alzheimer disease: Assuming that APs and NFTs are disease-causing alterations, the majority of the research efforts in the AD field initially focused on these lesions, revealing that amyloid beta (Aβ) peptide aggregates and hyperphosphorylated tau fibrils, respectively, are their prominent constituents [13].